Vaughn Bryan T 4

4 · LABCORP HOLDINGS INC. · Filed Feb 12, 2026

AI-generated summary of this filing

Updated Feb 12, 2026

Labcorp (LH) EVP Bryan T. Vaughn Receives Stock Awards

What Happened

Bryan T. Vaughn, Executive Vice President, Diagnostics at Labcorp Holdings Inc. (LH), received equity awards on February 10, 2026: a grant of 2,200 employee stock options and 730 Restricted Stock Units (RSUs).
The reported acquisition price for both awards is $0 (these are compensation grants, not an open-market purchase). The options give the right to buy shares in the future; each RSU represents a contingent right to one share.

Key Details

Transaction date: 2026-02-10; Form 4 filed 2026-02-12 (timely filing).
Options: 2,200 shares (Footnote F1). Vesting: three equal annual installments beginning on the grant date (2026-02-10) (Footnote F2).
RSUs: 730 units (Footnotes F3–F5). Vesting: three equal annual installments beginning February 10, 2027 (Footnote F4). Footnote F5 notes 730 reflects the aggregate RSUs held by the reporting person.
Reported consideration: $0 (standard for new grant awards).
Shares owned after transaction: not specified in the summary data provided in this request.

Context

These are compensation awards (common for executives) rather than open-market purchases or sales. Options provide the right to buy stock later (may require exercise and payment); RSUs convert to shares when they vest.
Because these are grants, they do not directly signal immediate buying or selling by the insider; they reflect company compensation decisions.

Form 4

Period: 2026-02-10

EVP, Diagnostics

Transactions

Award
Non-qualified Stock Options
[F1][F2]
2026-02-10+2,200→ 2,200 total
Exercise: $284.50From: 2027-02-10Exp: 2036-02-09→ Common Stock (2,200 underlying)
Award
Restricted Stock Unit
[F3][F4][F5]
2026-02-10+730→ 4,354 total
→ Common Stock (730 underlying)

Footnotes (5)

[F1]Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. 2025 Omnibus Incentive Plan.
[F2]The option vests in three equal annual installments beginning on the date reflected in this column.
[F3]Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
[F4]The Restricted Stock Units vest in three equal annual installments beginning on February 10, 2027.
[F5]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Signature

/s/ Kathryn W. Kyle, Attorney-in-Fact for Bryan T. Vaughn|2026-02-12

1 file